SIX has decided to make changes to the index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 19 September 2025 after closing. The adjustment takes effect on 22 September 2025.
Amrize qualifies for remaining in the SMI, SPI20, SLI, and SPI Large indices based on the updated selection list.
Changes to the SMI® and SPI®20 index baskets
Exclusion from the SMI® and SPI®20
|
SONOVA N |
CH0012549785 |
Changes to the SMIM® index basket
Admission to the SMIM®
|
SONOVA N |
CH0012549785 |
|
SWISSQUOTE N |
CH0010675863 |
|
ACCELLERON N |
CH1169360919 |
|
SUNRISE N |
CH1386220409 |
Exclusion from the SMIM®
|
ams-OSRAM |
AT0000A3EPA4 |
|
BKW N |
CH0130293662 |
|
TECAN GROUP AG N |
CH0012100191 |
|
GALENICA N |
CH0360674466 |
Changes to the SLI® index basket
Admission to the SLI®
|
Galderma Group N |
CH1335392721 |
Exclusion from the SLI®
|
ADECCO N |
CH0012138605 |
|
SIG Group N |
CH0435377954 |
SLI® 9% cappings
Based on the SLI® index rules, section 5.16.4, and according to the capping selection list 9%1, the weight of the following securities will be limited to 9%:
|
NESTLE N |
CH0038863350 |
|
NOVARTIS N |
CH0012005267 |
|
ROCHE GS |
CH0012032048 |
| UBS GROUP N | CH0244767585 |
Changes to the SPI® Small, Mid and Large index baskets
Changes from SPI® Mid to SPI® Large
|
NO CHANGES |
Changes from SPI® Large to SPI® Mid
|
KUEHNE+NAGEL INT N |
CH0025238863 |
Changes from SPI® Small to SPI® Mid
|
LIECHT LANDBK N |
LI0355147575 |
|
BURKHALTER N |
CH0212255803 |
|
MEDACTA GROUP N |
CH0468525222 |
Changes from SPI® Mid to SPI® Small
|
DocMorris N |
CH0042615283 |
|
KOMAX N |
CH0010702154 |
|
BYSTRONIC N |
CH0244017502 |
|
LEM N |
CH0022427626 |
Changes to the SXI Life Sciences®
Admission to the SXI Life Sciences®
|
SANTHERA N |
CH1276028821 |
Exclusion from the SXI Life Sciences®
|
XLIFE SCIENCES N |
CH0461929603 |
Changes to the SXI Bio+Medtech®
Admission to the SXI Bio+Medtech®
|
SANTHERA N |
CH1276028821 |
Exclusion from the SXI Bio+Medtech®
|
XLIFE SCIENCES N |
CH0461929603 |
Changes to the SXI Swiss Real Estate® Funds
|
NO CHANGES TO THE INDEX COMPOSITION |
Changes to the SXI Swiss Real Estate® Shares
|
NO CHANGES TO THE INDEX COMPOSITION |
Further Links
The equity selection list, which is compiled four times a year on the basis of the admission and exclusion criteria, is available on the website[1]:
[1] Access to the Closed User Group required.
